2008
DOI: 10.1097/bsd.0b013e31814cf51d
|View full text |Cite
|
Sign up to set email alerts
|

The Effects of Lentiviral Gene Therapy With Bone Morphogenetic Protein-2-Producing Bone Marrow Cells on Spinal Fusion in Rats

Abstract: The present study demonstrated that BMP-2-producing RBMCs, created through lentiviral gene transfer, induced sufficient spinal fusion. The use of lentiviral vectors that contain the cDNA for BMP-2 will be a novel and promising approach for a spinal fusion strategy.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
29
0

Year Published

2009
2009
2021
2021

Publication Types

Select...
8

Relationship

4
4

Authors

Journals

citations
Cited by 42 publications
(30 citation statements)
references
References 33 publications
1
29
0
Order By: Relevance
“…Lentiviruses are also able to transduce a wide variety of cells, including non-dividing cells, and can integrate into the genome to provide sustained gene expression. With respect to bone growth, Miyazaki et al (2008) showed that BMP-2-producing rat bone marrow cells created through lentiviral gene transfer induced sufficient spinal fusion in rats. Zhang et al (2002) reported that lentiviral vectors were able to transduce human bone marrow-derived stromal cells through many cell divisions and during differentiation into adipocytes.…”
Section: Discussionmentioning
confidence: 99%
“…Lentiviruses are also able to transduce a wide variety of cells, including non-dividing cells, and can integrate into the genome to provide sustained gene expression. With respect to bone growth, Miyazaki et al (2008) showed that BMP-2-producing rat bone marrow cells created through lentiviral gene transfer induced sufficient spinal fusion in rats. Zhang et al (2002) reported that lentiviral vectors were able to transduce human bone marrow-derived stromal cells through many cell divisions and during differentiation into adipocytes.…”
Section: Discussionmentioning
confidence: 99%
“…Due to the short half-life and heterotopic ossification seen with locally administered BMP, studies have examined the use of gene therapy to increase BMP production at the site of bone defects and spinal fusions [15,[35][36][37]. In a goat model for ON, Tang and colleagues were able to show the formation of lamellar bone using a β-tricalcium phosphate (β-TCP) scaffold loaded with BMP-2 gene-modified MSCs [22].…”
Section: Animal Studies Investigating Bone Morphogenetic Proteins Formentioning
confidence: 99%
“…Bone regeneration is modulated by various cellular mediators including bone morphogenetic proteins (BMP), angiogenic growth factors, interleukins, and cytokines, all of which have been used to treat bone defects [13][14][15][16]. It is thought that through use of these agents alone or in combination with an operative procedure, healing of ON lesions can be enhanced (see Tables 1 and 2).…”
Section: Adjuvant Growth Factorsmentioning
confidence: 99%
“…Various improvements have been implemented to ensure such safety [82,97,114], and gene therapy has been validated as a safe technique in preclinical animal experiments [13,30,43,64,70,99,101]. However, long-term results have not yet been elucidated, and further studies are required before these vectors can be used in clinical practice.…”
Section: Gene Therapymentioning
confidence: 99%
“…Host immunity destroys the transduced cells and reduces the effect of transgene expression. Recently, in order to compensate the disadvantage of adenoviral vectors, various viral vectors such as adeno-associated viral vector and lentiviral vector, have been tested [26,64,83].…”
Section: Gene Therapymentioning
confidence: 99%